Peripheral Vascular Devices Market, by Product Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty Balloon Catheters, PTA Guidewires, Atherectomy Devices, Chronic Total Occlusion Devices, Aortic Stents, Synthetic Surgical Grafts, Embolic

Peripheral Vascular Devices Market, by Product Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty Balloon Catheters, PTA Guidewires, Atherectomy Devices, Chronic Total Occlusion Devices, Aortic Stents, Synthetic Surgical Grafts, Embolic Protection Devices, and Inferior Vena Cava Filters), by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Peripheral vascular disease (PVD), also known as arteriosclerosis obliterans, arterial insufficiency of the legs, claudication, or intermittent claudication, is a blood circulation disorder that causes the blood vessels in the heart or brain to narrow, spasm or block. Peripheral vascular disease usually causes fatigue and pain in the legs and particularly during strenuous physical activities, which usually subsides with rest. The blood vessels supplying oxygenated blood to the arms, kidneys, intestines, and stomach are usually affected by the peripheral vascular diseases.

Peripheral vascular devices market includes IVC (inferior vena cava) filters, angiography catheters, EVAR (Endovascular Aortic Aneurysm Repair) stent-grafts, hemodynamic flow alteration, and plague modification devices are used for treating peripheral arterial or coronary arterial disease and also used in the peripheral endovascular and coronary procedure. These devices are used to decrease the interference of patients with a minimum disturbance during the surgical procedure.

Market Dynamics

The rising global prevalence of venous diseases or CVI (Chronic Venous Insufficiency) is expected to drive the global peripheral vascular devices market. Some of the other drivers of this market include increasing demand for minimally invasive endovascular procedures on account of their shorter recovery time, lesser scaring, and lesser chances of post-surgery infections. In addition, growing prevalence of disease-causing lifestyle and eating habits such as high consumption of alcohol, tobacco products, and smoking cigarettes is expected to boost peripheral vascular devices market demand by triggering the incidence rates of cardiac arrest, blood clotting, and other vascular diseases. Moreover, increase in the global geriatric population is also expected to drive the growth of the market. For instance, according to the world health organization (WHO), on 1 October, 2022, between 2015 and 2050, the proportion of the world's population over 60 years will nearly get double from 12% to 22% and by 2050, the world’s population of people aged 60 years and older will be around 2.1 billion.

Key features of the study:

• This report provides an in-depth analysis of the global peripheral vascular devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global peripheral vascular devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson, and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, and Bayer AG.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global peripheral vascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral vascular devices market

Detailed Segmentation:

• Global Peripheral Vascular Devices Market, By Product Type:
• Peripheral Vascular Stents
• Peripheral Transluminal Angioplasty Balloon Catheters
• PTA Guidewires
• Atherectomy Devices
• Chronic Total Occlusion Devices
• Aortic Stents
• Synthetic Surgical Grafts
• Embolic Protection Devices
• Inferior Vena Cava Filters
• Global Peripheral Vascular Devices Market, By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Global Peripheral Vascular Devices Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Abbot Laboratories *
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Boston Scientific Corporation
• Angioscore
• Emboline Inc.
• Becton Dickinson, and Company
• Cook Group Inc.
• Cordis Corporation
• Covidien PLC
• Edward Lifesciences Corporation
• Medtronic Plc
• Jude Medical
• Bayer AG

“*” marked represents similar segmentation in other categories in the respective section.